• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙阿斯图里亚斯第四医疗区多发性硬化症的患病率和发病率。

Prevalence and incidence of multiple sclerosis in healthcare district IV of Asturias, Spain.

作者信息

Oliva-Nacarino Pedro, Simal Antuña Marina, Santos Varela Carmen, Villafani Echazú Javier, Fernández Domínguez Jessica, García Rodríguez Raquel, Oterino Durán Agustín, Suarez Santos Patricia, Llaneza González Miguel Ángel

机构信息

Servicio de Neurología, Hospital Universitario Central de Asturias, Oviedo, Spain.

Instituto de Investigación Biosanitaria del Principado de Asturias (ISPA), Oviedo, Spain.

出版信息

BMC Neurol. 2025 Mar 5;25(1):85. doi: 10.1186/s12883-025-04108-5.

DOI:10.1186/s12883-025-04108-5
PMID:40045217
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11881357/
Abstract

BACKGROUND

Multiple sclerosis is an inflammatory demyelinating autoimmune disease of the central nervous system. Studies conducted in recent years point to an increase in its prevalence and a change in the age profile of patients. This study aims to analyse the prevalence and incidence of multiple sclerosis in healthcare district IV of the region of Asturias, in north-western Spain.

METHODS

We conducted a retrospective epidemiological study of the population of said healthcare district with a diagnosis of multiple sclerosis according to the 2017 McDonald criteria. The prevalence of the disease was calculated cross-sectionally (prevalence date: December 31, 2022), while the incidence was determined retrospectively over a six-year period, from 2017 to 2022. We gathered data from the registries and databases of the tertiary hospital in healthcare district IV, and from one private hospital. Relevant demographic and clinical data were gathered from electronic records.

RESULTS

The prevalence of multiple sclerosis in the population studied was 198 cases per 100 000 population. The incidence of multiple sclerosis during the study period (2017-2022) was 6.6 cases per 100 000 person-years. On the prevalence date, 66.5% of patients were women and 82.4% presented relapsing-remitting multiple sclerosis. Mean age was 33.98 years at symptom onset and 50.84 years on the prevalence date.

CONCLUSIONS

Asturias currently presents the highest multiple sclerosis prevalence rate in Spain; the estimated rate represents an increase with respect to those reported in studies conducted in the same region in the 1990s.

摘要

背景

多发性硬化症是一种中枢神经系统的炎性脱髓鞘自身免疫性疾病。近年来的研究表明其患病率有所上升,且患者年龄分布发生了变化。本研究旨在分析西班牙西北部阿斯图里亚斯地区第四医疗区多发性硬化症的患病率和发病率。

方法

我们对该医疗区符合2017年麦克唐纳标准诊断为多发性硬化症的人群进行了回顾性流行病学研究。疾病患病率采用横断面计算(患病率日期:2022年12月31日),而发病率则回顾性确定为2017年至2022年的六年期间。我们从第四医疗区三级医院以及一家私立医院的登记处和数据库收集数据。相关人口统计学和临床数据从电子记录中收集。

结果

研究人群中多发性硬化症的患病率为每10万人198例。研究期间(2017 - 2022年)多发性硬化症的发病率为每10万人年6.6例。在患病率日期,66.5%的患者为女性,82.4%表现为复发缓解型多发性硬化症。症状出现时的平均年龄为33.98岁,在患病率日期时为50.84岁。

结论

阿斯图里亚斯目前是西班牙多发性硬化症患病率最高的地区;估计患病率相较于20世纪90年代在同一地区进行的研究所报告的患病率有所增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1df7/11881357/78996aea4337/12883_2025_4108_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1df7/11881357/e89b8ddb1efd/12883_2025_4108_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1df7/11881357/aaff20c5cd48/12883_2025_4108_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1df7/11881357/78996aea4337/12883_2025_4108_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1df7/11881357/e89b8ddb1efd/12883_2025_4108_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1df7/11881357/aaff20c5cd48/12883_2025_4108_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1df7/11881357/78996aea4337/12883_2025_4108_Fig3_HTML.jpg

相似文献

1
Prevalence and incidence of multiple sclerosis in healthcare district IV of Asturias, Spain.西班牙阿斯图里亚斯第四医疗区多发性硬化症的患病率和发病率。
BMC Neurol. 2025 Mar 5;25(1):85. doi: 10.1186/s12883-025-04108-5.
2
Epidemiology of multiple sclerosis in Santiago de Compostela (Spain).圣地亚哥-德孔波斯特拉(西班牙)多发性硬化症的流行病学。
Acta Neurol Scand. 2020 Sep;142(3):267-274. doi: 10.1111/ane.13265. Epub 2020 May 26.
3
Prevalence of multiple sclerosis in Health District III, Murcia, Spain.西班牙穆尔西亚第三卫生区多发性硬化症的流行情况。
Mult Scler Relat Disord. 2016 Sep;9:31-5. doi: 10.1016/j.msard.2016.06.003. Epub 2016 Jun 8.
4
Multiple sclerosis in Gijon health district, Asturias, northern Spain.
Acta Neurol Scand. 1997 Dec;96(6):375-9. doi: 10.1111/j.1600-0404.1997.tb00301.x.
5
Epidemiological study of multiple sclerosis in La Rioja.拉里奥哈地区多发性硬化症的流行病学研究。
Neurologia. 2015 Nov-Dec;30(9):552-60. doi: 10.1016/j.nrl.2014.04.016. Epub 2014 Jun 26.
6
Long-term epidemiology of multiple sclerosis in the Northern Seville District.塞维利亚北部地区多发性硬化症的长期流行病学研究。
Acta Neurol Scand. 2015 Aug;132(2):111-7. doi: 10.1111/ane.12363. Epub 2015 Feb 4.
7
[Multiple sclerosis incidence in the Alcoi Health district. 12-year-long study (1986-1997)].[阿尔科伊健康区的多发性硬化症发病率。为期12年的研究(1986 - 1997年)]
Rev Neurol. 2000;30(12):1128-31.
8
[Epidemiology of multiple sclerosis in Asturias].[阿斯图里亚斯地区多发性硬化症的流行病学]
Neurologia. 1991 Feb;6(2):41-5.
9
[The prevalence of multiple sclerosis in the Alcoi Health district].[阿尔科伊健康区多发性硬化症的患病率]
Rev Neurol. 2000;30(12):1131-4.
10
[The prevalence of multiple sclerosis in the city of Ourense, Galicia, in the north-west of the Iberian Peninsula].[伊比利亚半岛西北部加利西亚自治区奥伦塞市的多发性硬化症患病率]
Rev Neurol. 2020 Jul 1;71(1):19-25. doi: 10.33588/rn.7101.2019432.

引用本文的文献

1
Correction: Prevalence and incidence of multiple sclerosis in healthcare district IV of Asturias, Spain.更正:西班牙阿斯图里亚斯第四医疗区多发性硬化症的患病率和发病率
BMC Neurol. 2025 Mar 22;25(1):125. doi: 10.1186/s12883-025-04141-4.

本文引用的文献

1
Treatment of older patients with multiple sclerosis: Results of an International Delphi Survey.老年多发性硬化症患者的治疗:一项国际德尔菲调查的结果。
Mult Scler J Exp Transl Clin. 2023 Sep 13;9(3):20552173231198588. doi: 10.1177/20552173231198588. eCollection 2023 Jul-Sep.
2
Impact of aging on treatment considerations for multiple sclerosis patients.衰老对多发性硬化症患者治疗考量的影响。
Front Neurol. 2023 Jul 7;14:1197212. doi: 10.3389/fneur.2023.1197212. eCollection 2023.
3
Characterization of a late-onset multiple sclerosis Portuguese cohort.
一个迟发性多发性硬化葡萄牙队列的特征描述。
Mult Scler Relat Disord. 2023 Feb;70:104506. doi: 10.1016/j.msard.2023.104506. Epub 2023 Jan 7.
4
Incidence and prevalence of multiple sclerosis in Spain: a systematic review.西班牙多发性硬化症的发病率和患病率:系统评价。
Neurologia (Engl Ed). 2024 Oct;39(8):639-650. doi: 10.1016/j.nrleng.2022.02.004. Epub 2022 Nov 21.
5
The age at onset of relapsing-remitting multiple sclerosis has increased over the last five decades.在过去的五十年里,复发缓解型多发性硬化症的发病年龄有所增加。
Mult Scler Relat Disord. 2022 Dec;68:104103. doi: 10.1016/j.msard.2022.104103. Epub 2022 Aug 9.
6
Association of Multiple Sclerosis Prevalence With Sociodemographic, Health Systems, and Lifestyle Factors on a National and Regional Level.多发性硬化症患病率与国家和地区层面的社会人口统计学、卫生系统和生活方式因素的关联。
Neurology. 2022 Oct 17;99(16):e1813-e1823. doi: 10.1212/WNL.0000000000200962.
7
Apparent changes in the epidemiology and severity of multiple sclerosis.多发性硬化症的流行病学和严重程度的明显变化。
Nat Rev Neurol. 2021 Nov;17(11):676-688. doi: 10.1038/s41582-021-00556-y. Epub 2021 Sep 28.
8
Vitamin D deficiency in primary health care users at risk in Spain.维生素 D 缺乏症在西班牙的初级保健使用者中处于危险之中。
Nutr Hosp. 2021 Oct 13;38(5):1058-1067. doi: 10.20960/nh.03565.
9
Use of geographical information systems in multiple sclerosis research: A systematic scoping review.地理信息系统在多发性硬化症研究中的应用:系统范围综述。
Mult Scler Relat Disord. 2021 Jun;51:102909. doi: 10.1016/j.msard.2021.102909. Epub 2021 Mar 18.
10
The latitude gradient for multiple sclerosis prevalence is established in the early life course.多发性硬化症患病率的纬度梯度在生命早期阶段就已确立。
Brain. 2021 Aug 17;144(7):2038-2046. doi: 10.1093/brain/awab104.